Barclays downgrades Fortis stock rating on valuation concerns

Barclays downgraded Fortis to Equalweight from Overweight while raising its U.S.-dollar price target to $61 from $56, citing historically elevated valuation: a 35% premium to U.S. peers and nearly 10% to Canadian peers. Fortis’s Q3 2026 results beat estimates, with earnings of CAD 474 million, or CAD 0.92 per share versus CAD 0.9019 expected, and revenue of CAD 3.23 billion versus CAD 2.9 billion. Barclays also raised its Canadian-dollar target to CAD 83 from CAD 76, while noting Arizona election uncertainty and that the shares were trading around CAD 85.

Analysis

The investable signal is a valuation-versus-growth tension, not a deterioration in Fortis’s operating trajectory. Faster rate-base growth can support durable earnings, but regulated-utility value accrues over years while a premium multiple is vulnerable immediately to higher real yields, slower rate-base realization, or regulatory friction. A strong quarter is less useful if the beat came from timing or non-recurring items rather than recurring rate-base earnings; verify the earnings bridge, capex funding plan, and allowed-return assumptions before treating it as a new run-rate.

Over the next 1–3 months, the Arizona election outcome is a potential regulatory-sentiment catalyst, but the article does not establish the specific policy changes or earnings exposure. Treat it as a risk flag, not a quantified loss. Over 6–18 months, execution on incremental capital and rate-base conversion matters more than the quarter’s headline beat. The contradictory claim that there have been no recent analyst rating changes should also be checked against the explicit Barclays downgrade.

Contrarian point: a peak relative multiple does not by itself make Fortis a compelling short. Defensive demand and credible rate-base growth can sustain a premium, particularly if bond yields fall. The cleaner expression is relative underperformance if the premium compresses, rather than a large outright short. Barclays’ price targets are not independent valuation evidence, and the article’s USD and CAD targets should not be conflated.

Key Decisions for Investors

• Consider a measured underweight in Fortis versus a diversified regulated-utility peer basket; scale in rather than chase an immediate short. The thesis is multiple compression, not an earnings collapse. Reassess if the premium narrows without deterioration in growth or if recurring earnings and rate-base delivery materially exceed expectations.
• Keep a near-term alert on Arizona election certification and subsequent commission actions. Falsify the regulatory-risk thesis if the result does not translate into adverse decisions affecting Fortis’s allowed returns, project approvals, or rate recovery.
• Before adding to the position, verify whether the quarterly beat reflects recurring utility earnings and whether incremental capital has identified, financeable projects with acceptable returns. A weaker rate-base outlook or funding terms would strengthen the underweight; strong conversion into earnings would weaken it.
• Monitor long-term yields and relative valuation: a sustained decline in yields could preserve the premium and squeeze an outright short. Confirm the correct currency and basis for the cited targets, and resolve the article’s conflicting statements on analyst rating activity.